Important notification
04.09.2020 To the attention of Romanian manufacturers/authorised representatives/importers The use of the EUDAMED “actors” registration module and of the single […]
Important notification
24.08.2020 To the attention of Contract Research Organisations In the context of the COVID-19 pandemic, the NAMMDR stated on 17.03.2020 […]
Important notification
20.08.2020 To the attention of marketing authorisation holders As part of the EU-wide measures following the outcome of the assessment […]
Important notification
04.08.2020 To the attention of interested persons EMA press release on the Global regulatory workshop on COVID-19 therapeutics #2: agreement […]
Press release
09.07.2020 To the attention of interested persons EMA press release on the finalization of the opinion on the presence of […]
Important notification
01.07.2020 To the attention of interested persons EMA press release: International regulators provide guiding principles for COVID-19 clinical trials descarca […]
Important notification
18.06.2020 To the attention of interested persons We hereby inform you that starting with 18.06.2020, the submission of applications and […]
Important notification
16.06.2020 To the attention of interested persons The NAMMD would like to inform you about the 7th Romanian Pharmacovigilance Workshop […]
Important notification
03.06.2020 To the attention of interested persons List of references of observational studies of chloroquine and hydroxychloroquine in COVID-19 patients […]
Important notification
09.04.2020 To the attention of interested persons In addition to the NAMMDR important notification published on 18.03.2020 on submission of […]